Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological Standardization of Poa Pratensis Allergen Extract
NCT01430117Phase 2Completed
- Sponsor
- LETI Pharma
- Start
- Oct 2011
- Primary completion
- Feb 2012
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of poa pratensis allergen extract in allergic rhinitis due to grass pollen, sponsored by LETI Pharma. Started Oct 2011; status: completed.
02
Drugs
poa pratensis allergen extract
03
Conditions
allergic rhinitis due to grass pollen
Beyond the preview
Go deeper on NCT01430117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01430117.